CA966778A - Antigens and antibodies - Google Patents

Antigens and antibodies

Info

Publication number
CA966778A
CA966778A CA112,764A CA112764A CA966778A CA 966778 A CA966778 A CA 966778A CA 112764 A CA112764 A CA 112764A CA 966778 A CA966778 A CA 966778A
Authority
CA
Canada
Prior art keywords
antigens
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA112,764A
Inventor
Sidney Spector
Charles W. Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to CA219,741A priority Critical patent/CA985169A/en
Application granted granted Critical
Publication of CA966778A publication Critical patent/CA966778A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA112,764A 1970-05-13 1971-05-12 Antigens and antibodies Expired CA966778A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA219,741A CA985169A (en) 1970-05-13 1975-02-10 Method for the determination of an opium alkaloid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3699970A 1970-05-13 1970-05-13

Publications (1)

Publication Number Publication Date
CA966778A true CA966778A (en) 1975-04-29

Family

ID=21891894

Family Applications (1)

Application Number Title Priority Date Filing Date
CA112,764A Expired CA966778A (en) 1970-05-13 1971-05-12 Antigens and antibodies

Country Status (5)

Country Link
CA (1) CA966778A (en)
DE (1) DE2166716C3 (en)
DK (1) DK142145B (en)
GB (1) GB1320056A (en)
SE (4) SE389739B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
CN113968853B (en) * 2020-07-22 2022-09-16 中国农业大学 Hapten and artificial antigen of atropine alkaloid, and preparation method and application thereof

Also Published As

Publication number Publication date
DE2166716A1 (en) 1975-04-24
SE417970B (en) 1981-04-27
DK142145B (en) 1980-09-08
SE7408140L (en) 1974-06-19
SE389739B (en) 1976-11-15
SE389737B (en) 1976-11-15
GB1320056A (en) 1973-06-13
DE2166716B2 (en) 1979-09-27
DE2123300A1 (en) 1971-11-25
DK142145C (en) 1981-02-02
SE7408141L (en) 1974-06-19
DE2166716C3 (en) 1980-06-12
DE2123300B2 (en) 1976-03-04

Similar Documents

Publication Publication Date Title
CA988420A (en) Direct radioimmunoassay for antigens and their antibodies
CA982140A (en) Phenoxy-hydroxypropylamines and their preparation
AU462240B2 (en) Fusing process and device
CA962594A (en) Labeled antibody reagent
CA965351A (en) Carcinoembryonic antigen
CA936408A (en) Non-isoelectric protein and method
CA939180A (en) Toner materials and method
CA966778A (en) Antigens and antibodies
CA942555A (en) Development method and materials
CA1022923A (en) Antigens
CA955247A (en) Cephalosporins and preparation thereof
CA980337A (en) Hapten and antigen derivatives
AU459764B2 (en) Carcinoembryonic antigen
AU460071B2 (en) Carcinoembryonic antigen
CA842760A (en) Stabilized antigens and means for the production thereof
CA846123A (en) Photosensitive methods and materials
CA853628A (en) Photographic methods and materials
CA839754A (en) O-acylbenzohydroxamate and preparation thereof
CA1016183A (en) Thioxanthen-9-ones and preparation thereof
CA838091A (en) 1-substituted-3-cyclohexenes and preparation thereof
CA965797A (en) Bisphosphorylated imidodithiocarbonates and methods for their preparation
AU1646270A (en) Carcinoembryonic antigen
AU441197B2 (en) Novel thienodiazepines and preparations thereof
CA845173A (en) Heterolinear tetraphenylbutadienes and preparation
CA846850A (en) N-hexahydromethanoindanyl-dimethylthioureas and preparation